Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  SMAC mimetic LCL161
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
SMAC Mimetic LCL161 Alone or with Cyclophosphamide in Treating Patients with Relapsed or Refractory Multiple Myeloma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1381, NCI-2013-01276, CLCL161AUS01T, NCT01955434
LCL161 in Treating Patients with Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2013-0612, NCI-2014-01241, CLCL161AUS02T, NCT02098161
Start Over